Genentech breaks ground on $750 million Hillsboro, Oregon manufacturing expansion
The project adds 211,000 square feet and is targeted to begin commercial operations in 2031.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
The project adds 211,000 square feet and is targeted to begin commercial operations in 2031.
The expansion adds 211,000 square feet and is planned to begin commercial operations in 2031. Genentech expects about 250 high-wage jobs and about 200 construction jobs.
Genentech, a member of the Roche Group (SIX:RO, ROP; OTC:RHHBY), today broke ground on a $750 million expansion of its manufacturing facility in Hillsboro, Oregon, advancing plans announced in August to increase capacity for advanced drug delivery devices and to strengthen the company’s United Stat…